Q4 2025 Management View CEO Payman Khales reported that "sales and adjusted EPS towards the high end of the outlook range we provided in October." He stated for the full year, "sales increased 8% on a ...

Thank you, Kristen. This morning, we announced our fourth quarter and full-year 2025 financial results. Through diligent ...

Medical technology company Integer Holdings (NYSE:ITGR) reported in Q4 CY2025, with sales up 5% year on year to $472.1 million. The company expects the full year’s revenue to be around $1.85 billion, ...

Medical technology company Integer Holdings (NYSE:ITGR) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 11.1% year on year to $449.5 million. The company’s full-year revenue ...

Shares of Integer (NYSE: ITGR), a company specializing in the development and manufacturing of medical devices, saw a substantial decline of 32% on October 23, 2025. This notable drop was mainly due ...

Integer Holdings Corporation announced that it will release its financial and operational results for the fourth quarter and full year of 2024 on February 20, 2025, at 7 a.m. Central Time. Following ...

An audio replay will be available for seven days and can be accessed by dialing (800) 770-2030 or (609) 800-9909 and using Conference ID 3120125. The conference call will also be available live or via ...

PLANO, Texas, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) announced today that it will webcast its conference call discussing financial results and business highlights ...

PLANO, Texas, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for fourth quarter and full year ...